Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» J&J Diabetes Drug Faces Questions at FDA Advisory Panel
J&J Diabetes Drug Faces Questions at FDA Advisory Panel
J&J Diabetes Drug Faces Questions at FDA Advisory Panel
Submitted by
admin
on January 10, 2013 - 9:49am
Source:
Motley Fool
News Tags:
diabetes
FDA
JNJ
advisory panel
canagliflozin
Headline:
J&J Diabetes Drug Faces Questions at FDA Advisory Panel
Do Not Allow Advertisers to Use My Personal information
